STAT March 27, 2020
Andrew Joseph

Scientists are starting to roll out new blood tests for the coronavirus, a key development that, unlike the current diagnostic tests, will help pinpoint people who are immune and reveal the full scope of the pandemic.

The “serological” tests — which rely on drawn blood, not a nasal or throat swab — can identify people who were infected and have already recovered from Covid-19, including those who were never diagnosed, either because they didn’t feel particularly sick or they couldn’t get an initial test. Scientists expect those individuals will be safe from another infection for at least some time — so the tests could signal who could be prioritized to return to work or serve as a frontline health worker.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Provider, Technology
Ozempic And Other Weight Loss Drugs Will Only Work With Digital Health
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Bristol Myers taps startup to boost cell therapy production
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases

Share This Article